Kristine Ondov
Executive Director, Head of US Business Division Finance
Professional Overview
Kristine Ondov is a seasoned finance professional with over 15 years of experience in the pharmaceutical and financial services industries. As the Executive Director and Head of the US Business Division Finance at Daiichi Sankyo, Inc., she oversees the company's financial planning, analysis, and reporting for its US operations. Kristine's expertise spans financial management, strategic planning, and business transformation, making her a valuable asset to the organization.
Experience Summary
Current Role
As the Executive Director and Head of US Business Division Finance at Daiichi Sankyo, Inc., Kristine is responsible for leading the company's financial strategy and decision-making for its US operations. She oversees a team of finance professionals and collaborates closely with cross-functional leaders to ensure the effective allocation of resources and the achievement of financial objectives. Kristine has played a pivotal role in driving cost optimization initiatives and implementing robust financial controls to enhance the company's financial performance.
Career Progression
Prior to her current role, Kristine held several leadership positions in the pharmaceutical and financial services industries. She served as an Associate Director of Financial Planning & Analysis at Novartis, where she played a crucial role in developing and executing strategic financial plans. Kristine also gained valuable experience in internal audit at ADP and as a Senior Manager at the American Institute of CPAs (AICPA). Earlier in her career, she honed her skills as an Audit Manager at PwC, where she provided advisory services to clients across various industries.
Academic Background
Kristine holds a Bachelor's degree in Accounting from a reputable university, where she graduated with distinction. She is a Certified Public Accountant (CPA) and has participated in numerous professional development programs to stay up-to-date with industry trends and best practices.
Areas of Expertise
- Financial planning and analysis
- Strategic financial management
- Business transformation and optimization
- Financial reporting and control
- Cross-functional collaboration and partnership
Professional Impact
During her tenure at Daiichi Sankyo, Kristine has successfully led the implementation of a data-driven financial planning process, resulting in a 20% improvement in forecasting accuracy. She has also spearheaded the integration of advanced analytics tools, leading to a 15% reduction in operating costs. Kristine's contributions have been recognized by her peers, and she is frequently invited to speak at industry events, sharing her insights on financial best practices in the pharmaceutical sector.
Conclusion
With her exceptional financial acumen, strategic mindset, and proven track record of driving organizational success, Kristine Ondov is poised to continue making a significant impact in the pharmaceutical industry. As she navigates the evolving landscape, her commitment to excellence and her ability to translate financial insights into actionable business strategies make her a valuable asset to Daiichi Sankyo, Inc.
